SG Americas Securities
VIR icon

SG Americas Securities’s Vir Biotechnology VIR Stock Holding History

SG Americas Securities’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,284
Closed -$182K – 3690
2026
Q1 		$182K Sell
20,284
-39,112
-66% -$312K ﹤0.01% 2690
2025
Q4 		$358K Sell
59,396
-9,632
-14% -$57.4K ﹤0.01% 2668
2025
Q3 		$394K Buy
69,028
+31,553
+84% +$161K ﹤0.01% 2293
2025
Q2 		$189K Sell
37,475
-2,857
-7% -$15.3K ﹤0.01% 2289
2025
Q1 		$261K Buy
+40,332
New +$359K ﹤0.01% 2332
2024
Q1 		– Sell
-96,431
Closed -$970K – 3465
2023
Q4 		$970K Buy
96,431
+6,980
+8% +$63.8K 0.01% 1043
2023
Q3 		$838K Buy
+89,451
New +$1.28M 0.01% 1417
2023
Q2 		– Sell
-118,317
Closed -$2.75M – 3216
2023
Q1 		$2.75M Buy
118,317
+111,654
+1,676% +$2.86M 0.03% 511
2022
Q4 		$169K Sell
6,663
-4,984
-43% -$122K ﹤0.01% 2322
2022
Q3 		$225K Sell
11,647
-282
-2% -$7.17K ﹤0.01% 2222
2022
Q2 		$304K Sell
11,929
-21,822
-65% -$509K ﹤0.01% 2377
2022
Q1 		$868K Buy
33,751
+30,975
+1,116% +$919K 0.01% 1520
2021
Q4 		$116K Sell
2,776
-57,355
-95% -$2.25M ﹤0.01% 3003
2021
Q3 		$2.62M Buy
60,131
+23,427
+64% +$1.01M 0.01% 1042
2021
Q2 		$1.74M Sell
36,704
-5,223
-12% -$237K 0.01% 1207
2021
Q1 		$2.15M Buy
41,927
+18,876
+82% +$1.02M 0.01% 996
2020
Q4 		$617K Buy
+23,051
New +$749K ﹤0.01% 1831
2020
Q3 		– Sell
-24,614
Closed -$1.01M – 3489
2020
Q2 		$1.01M Buy
+24,614
New +$826K 0.01% 1411

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SG Americas Securities's VIR Position: Q2 2026 in Review

SG Americas Securities sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 20,284 shares — an estimated $182K sold.

SG Americas Securities first reported a position in VIR in Q2 2020 and held it in 18 quarters. The position peaked at $2.75M in Q1 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • SG Americas Securities reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 20,284 Vir Biotechnology shares in Q2 2026, an estimated $182K.
  • SG Americas Securities first reported a position in Vir Biotechnology in Q2 2020 and held it in 18 quarters.
  • SG Americas Securities's Vir Biotechnology position peaked at $2.75M in Q1 2023.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.